Hormones

A man on testosterone feels bloated and his nipples are sensitive. He reads that oestradiol is the problem, takes an aromatase inhibitor, and within two weeks his libido is gone, his joints ache and he cannot get an erection. He concludes his oestradiol must still be too high and takes more.
This sequence plays out constantly, and it runs in exactly the wrong direction.
Some testosterone converts to oestradiol through the aromatase enzyme, mostly in fat tissue. That conversion is normal physiology, not a side effect. Oestradiol in men is required for:
That combination is common and it is almost always self-inflicted.
This is the core of the problem. High and low oestradiol produce symptom lists that look alike.
| Symptom | High E2 | Low E2 |
|---|---|---|
| Low libido | yes | yes |
| Erectile difficulty | yes | yes |
| Fatigue | yes | yes |
| Mood disturbance | yes | yes |
| Water retention | yes | no |
| Nipple sensitivity | yes | no |
| Joint pain and dryness | no | yes |
| Loss of morning erections | sometimes | yes |
Notice the shape of it. Only two symptoms clearly point at high, and only two clearly point at low. Everything else is shared. Which means somebody taking an aromatase inhibitor for low libido, without knowing which direction they are actually in, has a coin-flip chance of making it worse. And because the symptoms continue, the instinct is to increase the dose.
The estrogen and AI dose calculator reads symptoms against labs for exactly this reason, rather than assuming a high number needs treating.
Before you do anything based on an oestradiol result, check which assay produced it. There are two in common use, and they are not interchangeable.
The standard immunoassay was designed for women, where oestradiol is far higher. At the low concentrations found in men it lacks accuracy, and it is prone to cross-reactivity that inflates the result.
The sensitive assay, usually liquid chromatography with mass spectrometry, measures accurately at male concentrations.
A standard immunoassay can read meaningfully higher than the sensitive assay on the same sample. A man whose true level is unremarkable can be told his oestradiol is high, take an aromatase inhibitor on the strength of it, and crash a hormone that was never elevated.
If you take one thing from this article: ask for the sensitive oestradiol assay by name. It is a different test, not a more expensive version of the same one. Most standard packages run the immunoassay by default.
The fear driving most aromatase inhibitor use is gynecomastia, and the mechanism is more specific than "high oestradiol".
Glandular breast tissue develops in response to the ratio of oestrogenic to androgenic signalling at the tissue, and to individual tissue sensitivity. Two men with identical oestradiol can have entirely different outcomes. Which is why:
That last point matters. If the driver is progestogenic rather than oestrogenic, blocking aromatase does nothing useful and simply crashes a hormone you needed.
If chest tissue has already developed, the question is whether it is glandular or fat, and how long the treatment window has been open. The gynecomastia assessment engine works through that and grades which class of medication the evidence actually supports.
In order.
1. Confirm the assay. If it was an immunoassay, the number is unreliable in a man. Retest with the sensitive assay before acting.
2. Read symptoms alongside the number, not instead of it. Water retention and nipple sensitivity point one way. Joint pain and dryness point the other. A number without symptoms rarely justifies intervention.
3. Consider the dose first. Oestradiol rises because testosterone is aromatising. Lowering the testosterone dose lowers oestradiol without introducing a second drug, and it is almost always the better first move.
4. Consider body fat. Aromatase activity is concentrated in adipose tissue. More fat means more conversion, and this is a slower lever but a real one.
5. Only then consider an aromatase inhibitor, at the lowest effective dose, with a prescriber, and with retesting to confirm where you have landed.
The error is skipping straight to step five.
Aromatase inhibitors are prescription medicines. In India they fall under the Drugs and Cosmetics Act, 1940, and lawful use requires a prescription from a registered medical practitioner.
There is also a practical reason. Individual response varies enormously, and these drugs are potent relative to the size of the hormone pool they act on. A dose that produces a mild reduction in one man crashes another. This is the single easiest thing to get badly wrong without monitoring, and the recovery takes weeks.
Reference ranges vary by laboratory and by assay. The more important point is which assay was used: a standard immunoassay is unreliable at male concentrations and tends to over-read, while a sensitive LC-MS/MS assay measures accurately. Compare against the range printed on your own report.
Joint pain and dryness, loss of libido, erectile difficulty, absent morning erections, low mood and fatigue. Several of these overlap with the symptoms of high oestradiol, which is why treating without testing goes wrong so often.
Most men do not. Aromatase inhibitors are frequently taken pre-emptively and frequently crash oestradiol below where men function well. Lowering the testosterone dose and reducing body fat both lower oestradiol without adding a second drug.
Suppressed oestradiol is one of the most common explanations. Oestradiol is required for male libido, and a good testosterone number alongside a crushed oestradiol produces exactly this. Other causes exist, which is what a proper differential is for.
An assay, usually liquid chromatography with mass spectrometry, that measures oestradiol accurately at the low concentrations found in men. The standard immunoassay was designed for female concentrations and over-reads in men. Ask for the sensitive assay by name.
It contributes, but the mechanism is about the ratio of oestrogenic to androgenic signalling and individual tissue sensitivity rather than an absolute number. Some compounds cause it through progestogenic activity, which an aromatase inhibitor does not address.
This article is educational and is not medical advice. See the medical disclaimer.
Want a programme built around your own numbers?
Work With Dinesh
Newsletter
One email when a new guide, calculator or breakdown goes live. Nothing else.